Salute e Benessere
PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"
The Guidance, which focuses on the efficiency and improvement of patient management in order to reduce the use of blood transfusions, is the result of extensive collaboration between international experts in multidisciplinary fields dedicated to improving patient outcomes, safety and quality of care. It is therefore also a useful practical guide to address the global problem of iron deficiency and anaemia, blood loss and coagulopathies with bleeding.
In particular, referring to sideropenia in cardiovascular disease and diabetes, within the WHO Guidelines Sucrosomal® Iron is the only oral iron mentioned and recognised. Evidence of extraordinary relevance for Sucrosomial® Technology, PharmaNutra Group's innovative delivery system, capable of protecting micronutrient molecules such as iron, increasing their absorption and improving their gastrointestinal tolerability.
An achievement of great impact, considering that iron deficiency remains the most widespread nutritional deficiency in the world today. The World Health Organisation document points out that anaemia is a common occurrence in people with both cardiovascular disease and diabetes. In fact, it is estimated that at least 170 million people worldwide with such comorbidities have anaemia.
:
PharmaNutra.it
investorrelation@pharmanutra.it
View original content:https://www.prnewswire.co.uk/news-releases/pharmanutra-spa-sucrosomial-iron-mentioned-in-the-guidelines-of-the-world-health-organisation-302409725.html